Help
Technical Support Information – Desktop Computers
In order to view the webcast, you must have a currently supported HTML5 compliant web browser with standards-based media playback support on supported versions of the Windows and Macintosh operating systems.
Video webcasts require that you have a broadband Internet connection with at least 600kbps of download connectivity. If you are having difficulty with playback of a video webcast, for example playback is buffering frequently, please check your internet connection. Downloadable audio-only MP3 files are available for each session.
If you are still having trouble viewing the webcasts, please carefully review the detailed System Requirements and Troubleshooting Steps webpage.
Using the Capital Reach Media Player
For each session, there may be two different versions of the media player. Some sessions may include video of the presenter.
- Slide video – video of the speaker's slide presentation is the default stream displayed in the player. This option displays all speaker mouse movements and videos included in presentations.
- Audio and slides – audio of the speaker's presentation is the default stream in the player. Static slide images in the slide presentations are synchronized to the audio stream.
Navigating the Presentation Webcast
The player offers several tools to navigate the presentation:
- "Browse Slides" icon – select the browse slides icon to navigate to any slide in the presentation by selecting the slide thumbnail image.
Player Tools
- "Speaker Information" icon – if available, displays information about the speakers and presentations in the session.
- "Download Media" icon – select this button to download an audio-only file of the session.
-
Playback Controls
- Play/Pause button – select this button to play or pause the default media stream of the player.
- Stop button – select this button to stop the default media stream of the player.
Mobile Device Support
Presentation playback is available on supported versions of Apple iOS devices (Apple iPad and iPhone) and Android devices with an enabled Internet connection and a currently supported web browser with standards based media playback support. Users of these devices can stream sessions to their mobile device. Users have the option to stream either slide presentation video or audio-only from the session. Please note that some advanced interactivity features of the desktop player may not be supported on the Apple iOS mobile devices.
Speaker Info
Career Development Workshop - Mentoring Lab: Optimizing Your Mentor-Mentee Relationship for Career Success (co-sponsored by Women in Endocrinology)
Career Development Workshop - Mentoring Lab: Optimizing Your Mentor-Mentee Relationship for Career Success
Alice Y Chang, MD, MSc
Mayo Clinic, Rochester, MN
Pamela L Mellon, PHD
Univ of California San Diego, La Jolla, CA
Pamela L. Mellon received her Ph.D. at UC Berkeley in 1975 where she discovered splicing in retroviruses and the myc oncogene. As a postdoctoral fellow with Dr. Tom Maniatis at Cal Tech then Harvard, she invented the technology of transient transfection for analysis of mammalian gene expression finding that transiently transfected genes could recapitulate tissue-specific gene expression and could be regulated by cellular differentiation in culture. As an Assistant Professor at The Salk Institute, she began her studies of glycoprotein hormones in reproduction, moving to UCSD in 1992 where she is now Distinguished Professor. Dr. Mellon's research program has provided seminal advances in the understanding of developmental and hormonal regulation of gonadotropins and gonadotropin-releasing hormone in vitro and in vivo. Dr. Mellon has been the Director of the Center for Reproductive Science and Medicine for many years (P50 grant) and holds additional grants. She is the Vice-Chair for Research for the Department of OB/GYN and Reproductive Medicine and the Director of the UCSD Transgenic Mouse Core (since 1994). She has served as President of Women in Endocrinology and Chair of the NIH Endocrinology Study Section and on the Council of The Endocrine Society. Dr. Mellon was awarded the Chancellor's Award for Excellence in Postdoctoral Scholar Mentoring (2013-2014), the Mentor Award of Women in Endocrinology for 2014, the Society for Neuroscience mentoring award in 2017, and the UCSD Health Sciences Mentoring Award. She is Director of the NIH T32 "Training in Reproductive Sciences", which was awarded a MENTOR award. She is also Director of the UCSD NICHD Women's Reproductive Health Research Center (K12 grant), a program that supports junior faculty OB/GYN physician/scientists. She is on the Board of the National Center for Leadership in Academic Medicine program for training junior faculty at UCSD. She has mentored 10 K awardees and trained 54 postdocs, 22 PhDs, and 32 Master's students many of whom are now Professors at prestigious Universities and Vice-Presidents, CEOs, or Senior Scientists at Biotechnology and Pharmaceutical companies.
Dana Gaddy, PhD
Texas A&M University, College Station, TX
Dana Gaddy, PhD. is a tenured Professor in the Department of Veterinary Integrative Biosciences at Texas A&M University. She received her PhD in Cell Biology focused on ovarian function in Dr. JoAnne Richard's lab at Baylor College of Medicine, completed her post-doctoral fellowship on neuroendocrine actions of Activin A at the Salk Institute in the laboratory of the late Dr. Wylie Vale, and was a faculty member at the University of Arkansas for Medical Sciences from 1996-2015. Dr. Gaddy's research interests have focused on multiple areas of bone metabolism and disease. Her research team was the first to demonstrate the effects of gonadal Inhibins and Activins on bone marrow cell differentiation, the in vivo bone anabolic effects of Inhibin A, as well as the correlation of circulating Inhibin levels and markers of bone turnover across the menopause transition. Dr. Gaddy's lab also studies the influence of age and exercise on disuse-associated bone and muscle loss in rodent models. More recent research interests on rare bone disease have focused on the low bone turnover disease in both humans with Down Syndrome (DS) and the anabolic effects of PTH or Sclerostin Antibody in mouse models of DS. Finally, using CRISPR/Cas9 to generate a known point mutation in alkaline phosphatase, Dr. Gaddy's lab generated the first large animal of hypophosphatasia (HPP), which recapitulates the bone, muscle and dental phenotype of human HPP, and now serves as a template for better replicating the processes of human bone remodeling in other human bone diseases. Dr. Gaddy has served the Endocrine Society on its Annual Meeting Steering Committee, as president of the Women in Endocrinology Society, on the Editorial Board and current Associate Editor of Endocrinology and Current Osteoporosis Research, and is currently an Associate Editor of Endocrinology.
Ellen W. Seely, MD
Brigham & Women's Hosp, Boston, MA
Dr. Seely received her MD from Columbia University College of Physicians and Surgeons and trained in Internal Medicine and Endocrinology and Metabolism at Brigham and Women's Hospital. Dr. Seely serves as Professor of Medicine at Harvard Medical School and Director of Clinical Research in the Endocrinology, Diabetes and Hypertension Division and Vice Chair for Faculty Development, Department of Medicine at Brigham and Women's Hospital. Her research focuses on the pregnancy complications gestational diabetes and preeclampsia and how to reduce future cardiometabolic risk in women with these pregnancy complications. She has served as chair of the Clinical Research Affairs Committee of the Endocrine Society and President of the Association for Patient Oriented Research. Dr. Seely is committed to training future clinical researchers and has been recognized for her mentorship by her receipt of many mentoring awards including 10 years of K24 funding from the NIH, a 2001 Clifford Barger Excellence in Mentoring from Harvard Medical School, the 2017 Women in Endocrinology Mentor Award and the 2017 Association for Clinical Translational Science Distinguished Educator Award as well as several awards from Brigham and Women's Hospital.
Felix Beuschlein, MD
University Hospital Zurich, Zurich, Switzerland
1. PERSONAL INFORMATION Beuschlein, Felix ORCID ID 0000-0001-7826-3984 Date of birth: 20.06.1969 www.endokrinologie.usz.ch 2. EDUCATION 13.01.05 Habilitation in Internal Medicine at the University of Freiburg 07/02-07/04 Completion of residency in Internal Medicine/Endocrinology (University of Freiburg) 07/00-07/02 Postdoctoral fellow at the University of Michigan, Ann Arbor 07/98-07/00 Residency in Internal Medicine/Endocrinology at the Dept. of Internal Medicine, Endocrinology Division, University of Freiburg, Germany 01/97-06/98 Internship at the Dept. of Internal Medicine, University of Würzburg 07.01.98 Doctoral degree (Dr. med.) by the Faculty of Medicine, University of Würzburg 1990-1996 Medical School, University of Würzburg, Germany 3. EMPLOYMENT HISTORY INCLUDING CURRENT POSITIONS since 04/17 Director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Second affiliation: Klinikum der Universität München, Munich, Germany (PI) 10/11-03/17 Head of Endocrine Outpatient Clinic, University of Munich 06/06-03/17 Head of Endocrine Research, University of Munich (W2 Professorship) 07/05-05/06 Provisional Head of Division for Endocrinology and Diabetology, University of Freiburg 4. INSTITUTIONAL RESPONSIBILITIES since 04/17 Clinical director and full professor at the faculty of medicine, University of Zurich 5. MEMBERSHIPS IN PANEL, BOARDS AND SCIENTIFIC REVIEWING ACTIVITIES since 2015 Member of the Annual Meeting Steering Committee of the Endocrine Society since 2007 Member of the Steering committee of the European Network for the Study of Adrenal Tumors (ENSAT), 2008-2016 Chairman, since 2016 Head of the ACC Working group 2012-2014 Member of the Research Affairs Core Committee of the Endocrine Society 2011-2014 Vice president of the German Endocrine Society (DGE) 06/03 Co-founder and advisory board member of “Adrenal, Hypertension and Steroids” (Section of the German Endocrine Society), 2006-2011 Chairman 03/99 Co-founder of “DGE-Junge Forschung aktiv”, YARE since 2017 Senior Editor of Endocrine Connections 2007-2012 Editorial Board member of Journal of Molecular Endocrinology 2007-2012 Editorial Board member of Journal of Endocrinology 2011-2016 Coordinator of an FP7 Consortium (ENSAT-CANCER) 6. PRIZES, AWARDS AND FELLOWSHIPS 09/17 Ray A. Croc and Robert L. Croc Visiting Professorship 07/13 Rolf-Becker Award 2013 for the best publication at the LMU medical faculty 03/13 European Journal of Endocrinology Prize 2013 06/05 Merck Senior Fellow Award awarded by the Endocrine Society 07/04 Junior-Research-Group-Leader awarded by the Landesstiftung Baden-Württemberg 03/03 Schöller-Junkmann Award of the German Endocrine Society 01/02 Marius Tausk Award of the German Endocrine Society
Christopher Rolland McCartney, MD
University of Virginia School of Medicine, Charlottesville, VA
Dr. McCartney went to medical school and completed Internal Medicine residency training in his home state of Mississippi. He moved to Charlottesville, VA, in 1999 to enter the Endocrinology and Metabolism Fellowship Program at the University of Virginia (UVA), which he completed in 2002. While he had planned to return to the University of Mississippi as a clinician-educator, he decided to stay in Charlottesville to pursue clinical research. Given a passion for teaching/mentorship, he increasingly became involved with fellow education (in addition to medical student and resident teaching). Dr. McCartney was inducted into the UVA Dean's Academy of Distinguished Educators in 2011, and in the same year he became Program Director for the Endocrinology and Metabolism Fellowship Program at UVA. He has been a member of Council for the Association of Program Directors in Endocrinology and Metabolism (APDEM) since 2014, serving as Secretary-Treasurer (2016-2017), President-Elect (2017-2018), and President (2018-2020).
Download Media
Index
Browse Slides
Media Quality
Media quality is automatically adjusted based on the speed of your internet connection. If you would prefer to control the quality explicitly, please choose from the options above.